Biofrontera Inc. (BFRI)
NCM · Healthcare · Drug Manufacturers - Specialty & Generic
$0.86
-2.37%
Closing price as of 2026-06-12 · Source: TEK2day Finance
Key Metrics
Market Cap
$11.1M
Shares Outstanding
12.8M
P/S (TTM)
0.3x
Exchange
NCM
Currency
USD
About Biofrontera Inc.
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.
Quarterly Financials
| Metric | 2025-06-30 | 2025-09-30 | 2025-12-31 | 2026-03-31 |
|---|---|---|---|---|
| Revenue | 9.0M | 7.0M | 17.1M | 10.1M |
| Gross Profit | 6.4M | 4.9M | 14.1M | 8.0M |
| Operating Income | -5.1M | -6.3M | 4.6M | -3.9M |
| Net Income | -5.3M | -6.6M | 5.6M | -4.8M |
| Diluted EPS | $-0.57 | $-0.62 | $0.48 | $-0.41 |
Annual Financials
| Metric | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Revenue | 28.7M | 34.1M | 37.3M | 41.7M |
| Gross Profit | 13.5M | 16.6M | 18.7M | 30.7M |
| Operating Income | -22.4M | -22.6M | -17.2M | -11.3M |
| Net Income | -640K | -20.1M | -17.8M | -10.5M |
| Diluted EPS | $-0.48 | $-13.02 | $-3.22 | $-0.90 |